Mitochondrial Medicine Society Update (2016) - Dr. Amy Goldstein - 4/3/2016

October 21, 2020 01:04:57
Mitochondrial Medicine Society Update (2016) - Dr. Amy Goldstein - 4/3/2016
MitoAction Expert Series
Mitochondrial Medicine Society Update (2016) - Dr. Amy Goldstein - 4/3/2016

Oct 21 2020 | 01:04:57

/

Show Notes

Dr. Amy Goldstein provides an update on the Mitochondrial Medicine Society.

Areas of discussion include:

Centers of Excellence and the need for community involvement/input

About the Speaker

Dr. Amy Goldstein, a member of the Board of Trustees of UMDF, is on faculty at Children’s Hospital of Pittsburgh of UPMC in the Division of Pediatric Neurology. She is board certified in pediatrics, neurology, and psychiatry with Special Qualifications in Child Neurology. She is currently an Assistant Professor at the University of Pittsburgh School of Medicine. She began a multidisciplinary Mitochondrial Disease clinic in 2007 and is now the Director of Neurogenetics & Metabolism and the site Principle Investigator for NAMDC (the North American Mitochondrial Disease Consortium). She is also President of the Mitochondrial Medicine Society. Her clinical research interests include improving fatigue and exercise intolerance as well as developing common patient-centered outcome measures for clinical trials.

 

To view the accompanying slides, click here.

Other Episodes

Episode

May 19, 2022 01:12:36
Episode Cover

To Work or Not to Work

To work or not to work...that is the question Many adults with mitochondrial disease face a difficult decision about how to financially support themselves...

Listen

Episode 0

May 20, 2021 00:59:18
Episode Cover

Clinical Trials: Why you should care and why you should participate. How do we know what we know?

Join MitoAction and Dr. Jerry Vockley from University of Pittsburgh Children’s Hospital on Friday, May 14, 2021 for our monthly expert series presentation! About...

Listen

Episode

November 21, 2025 01:20:23
Episode Cover

Understanding Rare Genetic Variants: What Do My Results Really Mean?

When a genetic variant is shared by only a handful of individuals worldwide, what does it mean for diagnosis, treatment, and research? In this...

Listen